Existing research provides important information, but it does not answer every long-term question
The evidence consistently identifies several factors that increase risk further: Higher doses (the weight-loss doses of semaglutide and tirzepatide carry higher risk than the lower diabetic doses) Longer duration of treatment Faster rate of weight loss Pre-existing gallstones even asymptomatic ones found on a previous scan Female sex, age over 40, and family history of gallstones (the standard baseline risk factors, amplified by GLP-1 therapy) If several of these apply to you, the risk-benefit balance of your treatment plan is worth a structured discussion
A legitimate Orange County clinic should evaluate medical history, current medications, symptoms, appropriate lab considerations, and weight-related goals before recommending treatment
Sikiric P, Seiwerth S, et al
Existing research indicates that inhibiting the generation of ROS can effectively reduce inflammatory responses and improve intestinal function in UC patients ( Based on the above situation, Tan et al
Is vitamin B12 better taken in the morning or at night